AIZ
47
-7
ILMN
46
-6
JBHT
35
3
DOW
23
-3
CMA
55
-6
HSY
24
-3
MNST
52
-2
INTU
69
-5
MDLZ
40
2
MAR
66
-6
COST
50
-4
PBI
46
-2
IPG
47
5
AEE
69
-5
CAT
48
-3
BXP
42
-8
MPC
44
-6
BAC
57
-9
KMI
67
-6
TXN
60
-6
AIZ
47
-7
ILMN
46
-6
JBHT
35
3
DOW
23
-3
CMA
55
-6
HSY
24
-3
MNST
52
-2
INTU
69
-5
MDLZ
40
2
MAR
66
-6
COST
50
-4
PBI
46
-2
IPG
47
5
AEE
69
-5
CAT
48
-3
BXP
42
-8
MPC
44
-6
BAC
57
-9
KMI
67
-6
TXN
60
-6
Financhill
Back

Givaudan SA Vs. SpringWorks Therapeutics Industry Stock Comparison

Buy
82

GVDNY
Givaudan SA

Last Price:
$98.03
Seasonality Move:
4.12%
Sell
30

SWTX
SpringWorks Therapeutics

Last Price:
$46.28
Seasonality Move:
-7.9%
Buy
82
Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

  • The current Givaudan SA [GVDNY] share price is $99.17. The Score for GVDNY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
30
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $46.21. The Score for SWTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

  • The Givaudan SA share price today is $99.17
    The current trend is moderately bullish and GVDNY is experiencing selling pressure, which indicates risk of future bearish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $46.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

GVDNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.84 Buy
Relative Strength Index (14 RSI): 64.36 Buy
Chaikin Money Flow: -8606 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.13 - 98.05) Buy
Bollinger Bands (100): (85.52 - 93.86) Buy

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 58.07 Buy
Chaikin Money Flow: -6067159 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.64 - 47.62) Buy
Bollinger Bands (100): (37.09 - 51.29) Buy

GVDNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.97 Buy
20-day SMA: 96.45 Buy
50-day SMA: 92.04 Buy
200-day SMA: 93.44 Buy
8-day EMA: 97.82 Buy
20-day EMA: 96.13 Buy
50-day EMA: 93.3 Buy
200-day EMA: 91.18 Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.19 Buy
20-day SMA: 46.07 Buy
50-day SMA: 44.51 Buy
200-day SMA: 39.95 Buy
8-day EMA: 46.16 Buy
20-day EMA: 45.41 Buy
50-day EMA: 44.8 Buy
200-day EMA: 41.77 Buy

Givaudan SA Earnings Growth & GVDNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.

Givaudan SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):